In addition, the infectivity of the SARS-CoV-2 Delta variant, which utilizes both TMPRSS2-mediated and cathepsin-mediated membrane fusion for viral infection, could be lowered by inhibitors of either pathway. Here, TMPRSS2 is linked to viral infectious disease.